Efficacy of Oral Spironolactone in the Treatment of Androgenetic Alopecia in Female Patients: A Case Series of 11 Patients

    January 2025
    Lina Benchekroun, Hanane Darghal, Lina Mouline, Nadia Ismaïli, Laïla Benzekri, Mariame Meziane
    Image of study
    TLDR Spironolactone is generally safe and effective for treating hair loss in women, but may be less effective in severe cases.
    This case series evaluated the efficacy and safety of oral spironolactone in 11 female patients with androgenetic alopecia (AGA). Patients were treated with spironolactone at doses of 25 mg to 100 mg daily, in combination with other therapies such as topical minoxidil and platelet-rich plasma, over 6 to 36 months. Ten patients showed a one-grade improvement on the Sinclair scale, while one patient with severe AGA did not respond, likely due to poor adherence. The treatment was generally well tolerated, with mild side effects like mastodynia and menstrual irregularities. The study suggests spironolactone is a safe and effective treatment for female AGA, though its efficacy may be limited in advanced cases, and further large-scale trials are needed.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 475 results

    Related Research

    3 / 3 results